TheProfitWatch

ATAI - ATAI Life Sciences N.V. Common Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
6.37 -0.37 (-5.81%) --- 0.0 (0.0%) 0.04 (0.67%) -0.23 (-3.61%) -0.17 (-2.78%) 0.03 (0.5%) 0.03 (0.5%)

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.14
Diluted EPS:
-0.14
Basic P/E:
-42.8571
Diluted P/E:
-42.8571
RSI(14) 1m:
100.0
VWAP:
6.0
RVol:
0.9968

Events

Period Kind Movement Occurred At

Related News